Transcriptionally Active Syncytial Aggregates in the Maternal Circulation May Contribute to Circulating Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia

Transcriptionally Active Syncytial Aggregates in the Maternal Circulation May Contribute to Circulating Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia

<p style="text-align:justify;"> The cardinal manifestations of the pregnancy-specific disorder preeclampsia, new-onset hypertension, and proteinuria that resolve with placental delivery have been linked to an extracellular protein made by the placenta, soluble fms-like tyrosine kina...

Bibliografske podrobnosti
Main Authors:	Rajakumar, A, Cerdeira, AS, Rana, S, Zsengeller, Z, Edmunds, L, Jeyabalan, A, Hubel, CA, Stillman, IE, Parikh, SM, Karumanchi, SA
Format:	Journal article
Jezik:	English
Izdano:	American Heart Association 2012

Podobne knjige/članki

Soluble fms-Like Tyrosine Kinase 1 Localization in Renal Biopsies of CKD
od: Zsuzsanna K. Zsengellér, et al.
Izdano: (2019-12-01)

Circulating soluble fms-like tyrosine kinase-1 is placentally derived in normal pregnancy: first in vivo evidence
od: Cerdeira, AS, et al.
Izdano: (2019)

Impaired renal reserve contributes to preeclampsia via the kynurenine and soluble fms–like tyrosine kinase 1 pathway
od: Vincent Dupont, et al.
Izdano: (2022-10-01)

Soluble Fms-Like Tyrosine Kinase-1 Alters Cellular Metabolism and Mitochondrial Bioenergetics in Preeclampsia
od: Lissette C. Sánchez-Aranguren, et al.
Izdano: (2018-03-01)

Predictive accuracy of soluble FMS-like tyrosine kinase-1/placental growth factor ratio for preeclampsia in Japan: a systematic review
od: Yamazaki, T, et al.
Izdano: (2020)

Soluble fms-like tyrosine kinase 1 and placental growth factor ratio for predicting preeclampsia in elderly gravida
od: Vorapong Phupong, et al.
Izdano: (2020-04-01)

Antiangiogenic Biomarker Soluble Fms-like Tyrosine Kinase-1 in Pregnancy Complicated with Preeclampsia: A Cohort Study
od: Mandeep Kaur, et al.
Izdano: (2021-12-01)

One step closer to a cure for preeclampsia? Boosting the natural affinity of VEGF (vascular endothelial growth factor) to sFlt (soluble fms-like tyrosine kinase)-1
od: Cerdeira, AS, et al.
Izdano: (2020)

Placental Growth Factor, Soluble fms-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia
od: Carmen Rădulescu, et al.
Izdano: (2016-01-01)

Meta-analysis and systematic review to assess the role of soluble FMS-like tyrosine kinase-1 and placenta growth factor ratio in prediction of preeclampsia: The SaPPPhirE Study.
od: Agrawal, S, et al.
Izdano: (2017)

Soluble fms-like tyrosine kinase-1-to-placental growth factor ratio and time to delivery in women with suspected preeclampsia
od: Zeisler, H, et al.
Izdano: (2016)

Ruling out preeclampsia in the next 4 weeks using a soluble fms-like tyrosine kinase 1/placental growth factor ratio ≤38: secondary analysis of the Interventional Study on Prediction of Preeclampsia/Eclampsia in Women With Suspected Preeclampsia
od: Cerdeira, AS, et al.
Izdano: (2021)

The ratio of soluble fms–like tyrosine kinase 1 to placental growth factor predicts time to delivery and mode of birth in patients with suspected preeclampsia- a secondary analysis of the INSPIRE trial
od: Palma Dos Reis, CR, et al.
Izdano: (2024)

Is prolonging gestation in preeclampsia for better or worse in preventing cardiovascular disease?
od: Cerdeira, AS, et al.
Izdano: (2021)

The prognostic utility of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PIGF) biomarkers for predicting preeclampsia: a secondary analysis of data from the INSPIRE trial
od: Kifle, MM, et al.
Izdano: (2022)

An Elevated Maternal Plasma Soluble fms-Like Tyrosine Kinase-1 to Placental Growth Factor Ratio at Midtrimester Is a Useful Predictor for Preeclampsia
od: Mahmoud Fathy Hassan, et al.
Izdano: (2013-01-01)

Associations Between Soluble fms‐Like Tyrosine Kinase‐1 and Placental Growth Factor and Disease Severity Among Women With Preterm Eclampsia and Preeclampsia
od: Roxanne Hastie, et al.
Izdano: (2022-08-01)

Differences Ratio Level Soluble FMS-Like Tyrosine Kinase-1 and Placental Growth Factor Early And Late Onset on Preeclampsia and Normal Pregnancy
od: Ria Andina, et al.
Izdano: (2018-06-01)

The prognostic utility of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PIGF) biomarkers for predicting preeclampsia: a secondary analysis of data from the INSPIRE trial
od: Meron M. Kifle, et al.
Izdano: (2022-06-01)

Soluble Fms-Like Tyrosine Kinase-1 (Sflt-1) and Autoantibodies Against the AT1-Receptor in Preeclampsia in a Matched Pair, Blinded, Study Design.
od: Verlohren, S, et al.
Izdano: (2008)

Calcitonin gene-related peptide protects from soluble fms-like tyrosine kinase-1-induced vascular dysfunction in a preeclampsia mouse model
od: Akansha Mishra, et al.
Izdano: (2023-08-01)

The Predictive Value of Soluble Fms-Like Tyrosine Kinase-1 for Prognosis in COVID-19 Patients
od: Lai C, et al.
Izdano: (2025-03-01)

Evaluation of Serum Soluble fms-like Tyrosine Kinase-1 as a Biomarker in Ectopic Pregnancy
od: Alaa Raeed, et al.
Izdano: (2024-04-01)

Pengaruh Likopen terhadap Kadar Soluble FMS-Like Tyrosine Kinase 1 pada Preeklamsi
od: Vaulinne Basyir, et al.
Izdano: (2021-02-01)

Cereral Circulation in Preeclampsia
od: A. A. Ivshin, et al.
Izdano: (2008-02-01)

The soluble fms-like tyrosin kinase-1 (sFLT-1) to placental growth factor (PIGF) ratio as a possible indicator for the severity of preeclampsia - single institution experience
od: Andrijana Müller, et al.
Izdano: (2019-02-01)

Altered Level of Soluble fms-like Tyrosine Kinase 1 (sFlt1) and Hypoxia Inducible Factor-1alpha (HIF-1alpha) in Normotensive Pregnancy and Preeclampsia
od: John Wantania, et al.
Izdano: (2013-08-01)

Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia.
od: Melissa I March, et al.
Izdano: (2015-01-01)

Translation of mechanistic advances in preeclampsia to the clinic: long and winding road
od: Thadhani, R, et al.
Izdano: (2024)

Human umbilical cord mesenchymal stem cell derived exosomes (HUCMSC-exos) recovery soluble fms-like tyrosine kinase-1 (sFlt-1)-induced endothelial dysfunction in preeclampsia
od: Xinwen Chang, et al.
Izdano: (2023-08-01)

Serum heme oxygenase 1 (HO-1), soluble FMS like tyrosine kinase (sFlt-1) level, and neonatal outcome in early onset, late onset preeclampsia, and normal pregnancy
od: Muhammad Ilham Aldika Akbar, et al.
Izdano: (2018-10-01)

Circulating microparticles and immunomodulation in pregnancy and preeclampsia
od: Redman, C, et al.
Izdano: (2007)

An Examination of the Effect of Aspirin and Salicylic Acid on Soluble Fms-like Tyrosine Kinase-1 Release from Human Placental Trophoblasts
od: Jiawu Zhao, et al.
Izdano: (2024-01-01)

Diagnostic Accuracy of Different Soluble fms-Like Tyrosine Kinase 1 and Placental Growth Factor Cut-Off Values in the Assessment of Preterm and Term Preeclampsia: A Gestational Age Matched Case-Control Study
od: Evelyn A. Huhn, et al.
Izdano: (2018-11-01)

Prevalence of human respiratory syncytial virus circulating in Iran
od: Vahid Salimi, et al.
Izdano: (2016-03-01)

Role of vertical circulating exosomes biomarkers in preeclampsia
od: Ketki Kalele, et al.
Izdano: (2024-08-01)

Circulating concentrations of glycocalyx degradation products in preeclampsia
od: Niclas Carlberg, et al.
Izdano: (2022-10-01)

Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsia
od: Ai-ris Yonekura Collier, et al.
Izdano: (2019-07-01)

Association between serum soluble fms-like tyrosine kinase-1 and the central choroidal thickness during pregnancy: a prospective study
od: Ryo Asaoka, et al.
Izdano: (2021-09-01)

Soluble FMS-Like Tyrosine Kinase-1: Role in placenta accreta spectrum disorder [version 4; peer review: 2 approved]
od: Bancin Berry Eka Parda, et al.
Izdano: (2022-09-01)